An association between Epstein-Barr virus (EBV) infection and systemic lupus erythematosus (SLE) has been suggested from previous serologic evidence. Since most adults in Taiwan are EBV-infected, seroepidemiologic studies based on standard assays for EBV are unlikely to dissociate SLE patients and control groups. We reexamine this question by using novel methodologies in which IgA anti-EBV-coded nuclear antigens-1 (EBNA-1) and IgG anti-EBV DNase antibodies were analysed by ELISA, and EBV viral loads were detected by real-time quantitative PCR for 93 adult SLE patients and 370 age-, sex- and living place-matched healthy controls in Taiwan. The specificities of antibodies for extractible nuclear antigens were determined by Western blot. Our results show that IgA anti-EBV EBNA1 antibodies were detectable in 31.2% SLE patients but only in 4.1% of controls (odds ratio [OR] = 10.72, 95% confidence interval [CI] = 5.19–22.35; P < 10-7), IgG anti-EBV DNase antibodies were detected in 53.8% SLE patients but only in 12.2% controls (OR = 8.40, 95% CI = 4.87–14.51; P < 10-7). EBV DNA was amplifiable from the sera of 41.9% SLE patients but from only 3.24% controls (P < 0.05). A significant association of IgG anti-EBV DNase antibodies with anti-Sm/RNP antibodies was observed (P < 0.005). The higher seroreactivity and higher copy numbers of EBV genome indicated association of EBV infection with SLE in Taiwan.
von Muhlen C, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminar Arthritis & Rheum1995; 24: 323–358.
2.
Evans AS, Rothfield NF, Niederman JC. Raised antibody titers to E.B. virus in systemic lupus erythematosus. Lancet1971; I: 167–168.
3.
Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA1981; 78: 805–809.
4.
Rothfield NF, Evans AS, Niederman JC. Clinical and laboratory aspects of raised virus antibody titers in systemic lupus erythematosus. Ann Rheum Dis1973; 32: 238–245.
5.
Sculley DG, Sculley TB, Pope JH. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides. J Gen Virol1986; 67: 2253–2258.
6.
Kitagawa H, Iho S, Yokochi T, Hoshino T. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Lett1988; 17: 249–252.
7.
Peterson J, Rhodes G, Roudier J, Vaughan JH. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum1990; 33: 993–1000.
8.
Ngou J, Segondy JM, Seigneurin JM, Graafland H. Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue disease. J Med Virol1990; 32: 39–46.
9.
Ngou J, Graafland H, Segondy M. Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J Autoimmunity1992; 5: 243–249.
Tsai YT, Chiang BL, Kao YF, Hsieh KH. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int Arch Allergy Immunol1995; 106: 235–240.
12.
Rickinson AB, Kieff E. Epstein-Barr virus. In: Kinpes DM, Howley PM ed. Fields virology. Lippincott Williams and Wilkins, 2001: 2575–2627.
13.
McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med2005; 11: 85–89.
14.
James JA, Scofield RH, Harley JB. PPPGMRPP immunization generates anti-Sm humoral autoimmunity and induces systemic lupus erythematosus in rabbits. J Exp Med1995; 181: 453–461.
15.
James JA, Grosss T, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization. Ann NY Acad Sci1997; 815: 124–127.
16.
James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest1997; 100: 3019–3026.
17.
James JA, Neas BR, Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum2001; 44: 1122–1126.
18.
McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum2006; 54: 360–368.
19.
Chen MR, Liu MY, Hsu SM et al. Use of bacterially expressed EBNA-1 protein from a nasopharyngeal carcinoma (NPC) biopsy as a screening test for NPC patients. J Med Virol2001; 64: 51–57.
20.
Chen CJ, Lin KH, Lin SC et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol2005; 32: 44–47.
21.
Chen JY, Liu MY, Hsu TY, Cho SM, Young CS. Use of bacterially expressed antigen for detection of antibodies to the EBV-specific deoxyribonuclease in sera from patients with nasopharyngeal carcinoma. J Virol Meth1993; 45: 49–66.
22.
Tan EM, Choen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
23.
Lo YMD, Chan LYS, Lo KW et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res1999; 59: 1188–1191.
24.
Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of Sm D and Epstein-Barr virus-encoded nuclear antigen EBNA-1. Eur J Immunol1993; 23: 1146–1152.
25.
Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity2005; 38: 473–485.
26.
James JA, Harley J. B-cell epitope spreading in autoimmunity. Immunol Rev1998; 164: 185–200.
27.
Kang I, Quan T, Nolasco H et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol2004; 172: 1287–1294.
28.
Roberts ML, Luxembourg AT, Cooper NR. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection. J General Virol1996; 77: 3077–3085.
29.
Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Cell Immunol2005; 235: 29–38.
30.
Bauer G. Induction of Epstein-Barr virus early antigens by corticosteroids: inhibition by TPA and retinoic acid. Int J Cancer1983; 31: 291–295.
31.
Abo W, Imai S, Sugiura M et al. Effect of inhaled corticosteroids on EBV-specific cytotoxic T cells and EBV oropharyngeal excretion. Lancet1992; 340: 606–606.
32.
Moon MY, Park SJ, Oh ST et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther2004; 6: R295–R302.
33.
Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol2005; 174: 6599–6607.
34.
Garzelli C, Taub FE, Scharff JE, Prabhaker BS, Ginsberg-Fellner F, Notkins AL. Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J Virol1984; 52: 722–725.
35.
Gregory CD, Dive C, Henderson S et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature1991; 349: 612–614.
36.
Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA1993; 90: 8479–8483.
37.
Tsokos GC, Magrath GC, Balow JE. Epstein-Barr virus induces normal B-cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol1993; 131: 1797–1801.
38.
Kong PL, Odegard JM, Bouzahzah F et al. Intrinsic T cell dects in systemic autoimmunity. Ann NY Acad Sci2003; 987: 60–67.
